The global market for Oncaspar was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 281 million by 2031, growing at a CAGR of 11.4% during the forecast period.
Oncaspar is a cancer medicine used in adults and children to treat acute lymphoblastic leukaemia (ALL), a cancer of white blood cells called lymphoblasts. Oncaspar is used in combination with other...
The global market for Orally Disintegrating Tablet Excipient was valued at US$ 17830 million in the year 2024 and is projected to reach a revised size of US$ 22600 million by 2031, growing at a CAGR of 3.5% during the forecast period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medi...
The global market for Digoxin was valued at US$ 63.8 million in the year 2024 and is projected to reach a revised size of US$ 78.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Digoxin is used chronically in the therapy of cardiac arrhythmias, especially atrial fibrillation, at...
The global market for Levothyroxine Sodium was valued at US$ 3807 million in the year 2024 and is projected to reach a revised size of US$ 4607 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Levothyroxine Sodium is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland.
Abbvie was th...
The global market for Bacteriophage was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 177 million by 2031, growing at a CAGR of 19.3% during the forecast period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectivel...
The global market for Antihypertensive Beta Blockers was valued at US$ 18500 million in the year 2024 and is projected to reach a revised size of US$ 24340 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Antihypertensive beta blockers are a class of drugs that selectively bind to beta adrenergic receptors, thereby antagonizing the excitatory effects of neurotransmitters and...
The global market for Cancer Biosimilar Monoclonal Antibodies was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 14340 million by 2031, growing at a CAGR of 12.0% during the forecast period.
Cancer biosimilar monoclonal antibodies refer to biological products developed through strict approval procedures after the expiration of the original monoclonal an...
The global market for Anti-Asthma Short Acting Beta Agonists was valued at US$ 15000 million in the year 2024 and is projected to reach a revised size of US$ 19210 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Short acting beta agonists (SABAs) are bronchodilators primarily used to rapidly alleviate symptoms of acute asthma attacks. This type of drug belongs to phenylethyl...
The global market for Chain Pharmacy Prescription Drugs was valued at US$ 35000 million in the year 2024 and is projected to reach a revised size of US$ 40370 million by 2031, growing at a CAGR of 2.1% during the forecast period.
Prescription drugs play an increasingly crucial role in the operation of chain pharmacies. Prescription drugs refer to drugs that can only be dispensed, purchased, and us...
The global market for Erectile Dysfunction Drugs was valued at US$ 5450 million in the year 2024 and is projected to reach a revised size of US$ 8149 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual ac...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals